Holen Sie sich die Stockscreener-App
0.1988
6.12%
-0.0072
Schlusskurs vom Vortag:
$0.206
Offen:
$0.2
24-Stunden-Volumen:
309.50K
Relative Volume:
0.04
Marktkapitalisierung:
$6.93M
Einnahmen:
$9.37M
Nettoeinkommen (Verlust:
$-8.45M
KGV:
-0.2454
EPS:
-0.81
Netto-Cashflow:
$-7.27M
1W Leistung:
-49.11%
1M Leistung:
-64.19%
6M Leistung:
-84.89%
1J Leistung:
-90.33%
1-Tages-Spanne:
$0.1901
$0.2089
1-Wochen-Bereich:
$0.1639
$0.254
52-Wochen-Spanne:
$0.1639
$2.9893
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Firmenname
Bioaffinity Technologies Inc
Sektor
Branche
Telefon
210-698-5334
Adresse
3300 NACOGDOCHES ROAD, SAN ANTONIO
Vergleichen Sie BIAF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.1974 | 6.93M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
424.86 | 159.40B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
196.75 | 141.27B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
504.45 | 38.21B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.55 | 30.90B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
152.42 | 26.35B | 15.50B | 1.33B | 2.16B | 7.34 |
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
bioAffinity Technologies Completes $3.2M Public Offering - TipRanks
WallachBeth Capital Announces Closing of bioAffinity Technologies $3.25m Offering - The Malaysian Reserve
Independent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung Cancer - Yahoo Finance
bioAffinity announces $3.25 million securities offering By Investing.com - Investing.com Nigeria
bioAffinity Technologies completes $3.25 million offering By Investing.com - Investing.com South Africa
BioAffinity Technologies Closes $3.25 Million Offering - marketscreener.com
bioAffinity Technologies (BIAF) Completes $3.25M Securities Offering | BIAF Stock News - GuruFocus
bioAffinity Technologies completes $3.25 million offering - Investing.com
bioAffinity Technologies Announces Closing of $3.25 Million Offering - Bluefield Daily Telegraph
bioAffinity Technologies Boosts Data Acquisition for CyPath Lung Test - Medical Product Outsourcing
BioAffinity Technologies announces pricing of $3.25M offering - Yahoo Finance
Crude Oil Rises Sharply; US Trade Deficit Widens In March - Benzinga
The Zacks Analyst Blog Highlights Alphabet, Berkshire Hathaway, Visa and bioAffinity Technologies - NewsBreak: Local News & Alerts
Cancer Detection Biotech bioAffinity Secures Fresh $3.25M Funding: Key Details of Latest Stock Offering - Stock Titan
bioAffinity announces $3.25 million securities offering - Investing.com Australia
Dow Falls Over 250 Points; Marriott Posts Upbeat Earnings - Benzinga
Cancer Detection Biotech bioAffinity Raises $3.25M: Key Details of Stock Offering Revealed - Stock Titan
bioAffinity Technologies Announces Pricing of $3.25 Million Offering - Bluefield Daily Telegraph
Top Stock Reports for Alphabet, Berkshire Hathaway & Visa - Yahoo Finance
bioAffinity Technologies (NASDAQ:BIAF) Shares Up 2.7% – Still a Buy? - Defense World
bioAffinity Technologies streamlines lung cancer detection test By Investing.com - Investing.com Canada
bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost - BioSpace
bioAffinity Technologies streamlines lung cancer detection test - Investing.com
Bioaffinity Technologies Increases Efficiency Of Cypath Lung Test - marketscreener.com
Revolutionary Lung Cancer Detection Test Achieves 92% Accuracy While Slashing Costs by 25% - Stock Titan
ASP Isotopes and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Joplin Globe
bioAffinity Technologies Board Member Announces Departure - TipRanks
CyPath Lung Helped Detect Breast Cancer Recurrence - Medical Product Outsourcing
Bioaffinity Technologies Files For Resale Of Up To 3.0 Million Shares Of Common Stock By Selling StockholdersSEC Filing - marketscreener.com
bioAffinity Technologies Reports Record Revenue for 2024 - TipRanks
BIAF Stock Surges Post Improved Earnings and Record 2024 Revenues - Yahoo Finance
Earnings roundup: Usio back in the black; losses widen at bioAffinity, Wytec - San Antonio Express-News
bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Joplin Globe
bioAffinity Technologies Stock Price, Quotes and Forecasts | NASDAQ:BIAF - Benzinga
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Best Biotech Stocks To Follow Today – April 1st - Defense World
Biotech stock bioAffinity Technologies, Inc. (NASDAQ: BIAF) Makes NASDAQ Top Percentage Gainer on News - Investorideas.com
Take off with BioAffinity Technologies Inc (BIAF): Get ready for trading - Sete News
bioAffinity Technologies Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
bioAffinity Technologies (NASDAQ:BIAF) Given Hold Rating at Maxim Group - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Lung cancer spit test fast-tracks a San Antonio biotech company for growth - MSN
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Nasdaq Surges 1%; US Construction Spending Rises In February - Benzinga
Dow Dips Over 400 Points; ISM Manufacturing PMI Falls In March - Benzinga
What's Going On With BioAffinity Shares Tuesday? - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
bioAffinity Technologies stock hits 52-week low at $0.25 By Investing.com - Investing.com South Africa
bioAffinity Technologies, Inc. SEC 10-K Report - TradingView
bioAffinity Technologies earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
bioAffinity posts 270% revenue rise with Medicare coverage - Investing.com
Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.10%
1.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):